menu Search
Pemeta-100/Pemeta-500

Pemeta-100/Pemeta-500 Dosage/Direction for Use

pemetrexed

Manufacturer:

Admac Lifesciences

Distributor:

Orange Biotec
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Full Prescribing Info
Dosage/Direction for Use
Pemetrexed in combination with cisplatin: The recommended dose of Pemetrexed is 500 mg/m2 of body surface (BSA) administered as an intravenous infusion over 10 minutes on the first day of each 21 day cycle. The recommended dose of cisplatin is 75 mg/m2 BSA over two hours approximately 30 minutes after completion of the pemetrexed infusion on the first day of each 21 day cycle. Patients must receive adequate anti-emetic.
Pemetrexed as single agent: In patients treated for non-small cell lung cancer after prior chemotherapy, the recommended dose of pemetrexed is 500 mg/m2 BSA administered as an intravenous infusion over 10 minutes on the first day of each 21 day cycle.
Or as prescribed by the physician.